MED Share Price Performance
CHF 86.40
0.60 (0.70%)
9.1% undervalued intrinsic discount
CHF 95.00
Fair Value
Price CHF 86.40
AnalystConsensusTarget CHF 95.00
Fair ValueCHF 95.00
Share Pricen/a
Narrative Update • Jun 23
Medartis Holding AG Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
MED Community Narratives
AN
Fair Value
·Fair Value CHF 95 9.1% undervalued intrinsic discount
Orthopedic Demand And Digital Solutions Will Expand Global Reach
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Orthopedic Demand And Digital Solutions Will Expand Global Reach
Medartis makes implants used in bone and injury surgeries, and growing demand for these procedures could help it expand in faster-growing regions. A big question is whether it can keep profits steady as tariffs, currency swings, and a push into lower-priced products put pressure on costs.Read more
AN
CHF 95
9.1% undervalued intrinsic discount
Fair Value
Revenue
18.2% p.a.
Profit Margin
8.45%
Future PE
34.71x
Price in 2029
CHF 104.58
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
MED: Award Recognition And Steady Assumptions Will Support Future Upside
Fair Value: CHF 95 9.1% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Medartis Holding AG Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 18, 2026
- 0.67
- 75.89%
- 3.10%
- 47.3%
About MED
- Founded
- 1997
- Employees
- 1259
- CEO
- WebsiteView website
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
Recent MED News & Updates
Narrative Update • Jun 05
